Ferrostatin-1

Ferrostatin-1 has been studied in 29 papers since 2021: 3 observational studies in people, 19 in animals, 5 in cells, 2 reviews; 11 in the past year. It has not reached trials in people. The newest paper, Aug 22, 2026: “Estrogen signaling and ferroptosis in intervertebral disc degeneration: A proposed mechanistic framework and its evidence gaps”.

InterventionPreclinical

29 papers study it22 more mention it47 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 315% faster than aging research as a whole: 18 papers in the latest year counted

2 new papers in 30 daysSee all 51 papers on Ferrostatin-1

At a glance

Ferrostatin-1 extends lifespan and healthspan in a worm study; independent labs report improved cognition in mice and reduced senescence in mouse cells. Much of the work names the National Natural Science Foundation of China as a funder; funding also includes Eli Lilly, and an author works for BGI Group.

47 findings in 26 papers from 2021 to 2026, 8 of them since May 2026

The findings reach mice, none yet in people; independent labs found the same change in cells and mice. 24 independent labs in 3 countries.

None of its findings points the other way.

Cells and mice: replicated by independent labs. Worms or flies: a single group. Humans: nothing yet.
  • 24 independent labs in 3 countries
  • Funders: National Natural Science Foundation of China and others
  • 1 of 46 findings with company ties
  • Humans3
  • Animals18
  • Model organisms1
  • Cells5

What did studies of Ferrostatin-1 find?

42

Studies of Ferrostatin-1 measured 42 outcomes; the most studied are cellular senescence (4 studies), GPX4 (2) and cognitive function (2).

Cellular senescence

downin cells1downin human cells1downin mice1downin mouse cells1

4 studies
  1. Ferrostatin-1 decreases cellular senescence in Smo-deficient mice.

    “Inhibition of ferroptosis with ferrostatin-1 reversed hepatocyte senescence, restored hepatic blood flow, and improved both liver and kidney injury in Smo-deficient mice.”

    Animalsin Smo-deficient mice

    Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunction

    JCI insight

  2. Ferrostatin-1 decreases cellular senescence in cells (chemically and replicatively induced senescence).

    “effectively mitigate both chemically and replicatively induced senescence”

    Cellschemically and replicatively induced senescence

    Inhibition of Ferroptosis Delays Aging and Extends Healthspan Across Multiple Species

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  3. Ferrostatin-1 inhibits cellular senescence in human cells (NPs-induced senescence in STB cells).

    “inhibition of the ferroptosis signaling by ferrostain-1 (Fer-1) or deferiprone (DFP) ameliorated senescence induced by NPs in human STB cells”

    CellsNPs-induced senescence in STB cells

    Gestational exposure to nanoplastics disrupts fetal development by promoting the placental aging via ferroptosis of syncytiotrophoblast

    Environment international

  4. Ferrostatin-1 decreases cellular senescence in mouse cells (D-galactose-induced).

    “Ferrostatin-1 inhibited, whereas erastin increased, D-galactose induced, renal tubular cell senescence in vitro.”

    CellsD-galactose-induced

    Ferroptosis Activation Contributes to Kidney Aging in Mice by Promoting Tubular Cell Senescence

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Cellular senescence

GPX4

upin cells1upin human cells1

2 studies
  1. Ferrostatin-1 increases GPX4 in D-galactose and sodium iodate cellular models.

    “Pretreatment with Fer-1 alleviated ferroptosis by reducing iron levels and lipid peroxidation, and restored xCT/GPX4 expression.”

    Cellsin D-galactose and sodium iodate cellular models

    The contribution of ferroptosis to the epithelial-mesenchymal transition phenotype in models of age-related macular degeneration

    Frontiers in cell and developmental biology

  2. Ferrostatin-1 increases GPX4 in MPP+-induced cells.

    “upregulated the expression of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase-4 (GPX4) in MPP+-induced ferroptosis”

    Cellsin MPP+-induced cells

    p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells

    Toxicology in vitro : an international journal published in association with BIBRA

More on GPX4

Cognitive function

upin mice1upin rats1

2 studies
  1. Ferrostatin-1 improves cognitive function in rats (temporal lobe epilepsy).

    “but also improved cognitive performance in TLE rats, as evidenced by better outcomes in the Morris water maze and novel object recognition tests.”

    Animalstemporal lobe epilepsy

    Ketogenic diet improves cognitive impairment in rats with temporal lobe epilepsy by activating the Nrf2/HO-1/GPX4 signaling axis to inhibit ferroptosis

    Free radical biology & medicine

  2. Ferrostatin-1 improves cognitive function in PND mice.

    “Fer-1 can improve cognitive impairment in PND mice, as reflected by improved anxious exploration behavior and short-term working memory”

    Animalsin PND micemales

    tsRNA-5006c regulates hippocampal neurons ferroptosis to ameliorate perioperative neurocognitive disorders in aged male mice

    3 Biotech

Lipid peroxidation

downin cells1

1 study
  1. Ferrostatin-1 decreases lipid peroxidation in cells (AFB1 exposure).

    “Acsl4 silencing or Fer-1 treatment attenuated ACSL4 induction, GPX4 loss, lipid peroxidation and inflammatory injury.”

    CellsAFB1 exposure

    Aflatoxin B1-induced metabolic remodeling promotes liver injury through an H3K18la–ACSL4–ferroptosis axis attenuated by Urolithin A

    Metabolism: clinical and experimental

Efferocytosis

upin human cells1

1 study
  1. Ferrostatin-1 improves efferocytosis in human cells under FIN-56 treatment in THP-1-derived macrophages.

    “Ferrostatin-1 partially restored macrophage efferocytosis under FIN-56 treatment”

    Cellsunder FIN-56 treatment in THP-1-derived macrophages

    Rapamycin improves efferocytosis and reduces plaques in mice

    International immunopharmacology

Premature ovarian insufficiency

downin mice1

1 study
  1. Ferrostatin-1 protects against premature ovarian insufficiency in chronic sleep deprivation model.

    “whereas Ferrostatin-1 partially rescued the phenotype, establishing ferroptosis as a critical mediator.”

    Animalsin chronic sleep deprivation modelovaryfemales

    Chronic sleep deprivation induces ovarian ferroptosis and premature ovarian insufficiency linked to IL-17 signaling

    Life sciences

More on Premature ovarian insufficiency

Muscle atrophy

downin mice1

1 study
  1. Ferrostatin-1 decreases muscle atrophy in mice (aged sarcopenia mice).

    “pharmacological inhibition of iron overload or ferroptosis by DFO or ferrostatin-1 (Ferr-1) effectively ameliorated skeletal muscle atrophy and functional decline in aged sarcopenia mice”

    Animalsaged sarcopenia miceskeletal muscle

    NCOA4-Mediated Ferritinophagy Contributes to Iron Overload-Driven Ferroptosis of Senescent Myoblasts in Mice

    Cells

More on Muscle atrophy

Oxidative stress and ROS signaling

downin worms1

1 study
  1. Ferrostatin-1 protects against oxidative stress and ROS signaling in alcohol-exposed C. elegans.

    “generated reproductive toxicity and oxidative stress, while rescued by ferroptosis inhibitor Fer-1(100 μmol/L) and iron chelating agent DFO (50 μmol/L)”

    Model organismsin alcohol-exposed C. elegans100 μmol/L

    Exposure to Alcohol Causes Ferroptosis Activation Associated with Suppression of Heat Shock Responses-mediated iron metabolism disorder in Caenorhabditis elegans

    Food Science and Human Wellness

More on Oxidative stress and ROS signaling

IL-1β

downin rats1

1 study
  1. Ferrostatin-1 decreases IL-1β in rats (old rats treated with Fer-1 versus untreated old rats).

    “Transforming growth factor-β and interleukin-1β expression levels were elevated in the Old group and reduced following Fer-1 treatment.”

    Animalsold rats treated with Fer-1 versus untreated old ratsvocal fold2.5 μmol/kginjections at weeks 0 and 2; harvest at week 3males

    Effects of Ferrostatin-1 on Vocal Folds in Aging Rats

    The Laryngoscope

More on IL-1β

TGF-β signaling

downin rats1

1 study
  1. Ferrostatin-1 decreases TGF-β signaling in rats (old rats treated with Fer-1 versus untreated old rats).

    “Transforming growth factor-β and interleukin-1β expression levels were elevated in the Old group and reduced following Fer-1 treatment.”

    Animalsold rats treated with Fer-1 versus untreated old ratsvocal fold2.5 μmol/kginjections at weeks 0 and 2; harvest at week 3males

    Effects of Ferrostatin-1 on Vocal Folds in Aging Rats

    The Laryngoscope

More on TGF-β signaling

All 42

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One mouse study reports reduced sarcopenia with ferrostatin-1, another protection against premature ovarian insufficiency; a fly study reports longer lifespan in erastin- and RSL3-treated flies. A preprint reports reduced lipid peroxidation in D-galactose-treated human endothelial cells and reduced aortic elastic fiber disruption in iron-overloaded mice.

  2. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 7Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 4Jun 2026: 1Jul 2026: 1Aug 2026: 2Sep 2026: 3Oct 2026: 3Nov 2026: 025 papers in 12 months

See all 51 papers on Ferrostatin-1